For every Amazon, there are a dozen Pet.Coms, eToys and Webvans. For every Bill Gates and Steve Jobs, there are thousands of ...
Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.
Weight loss gummies claim to burn fat, suppress hunger, and boost your metabolism to help with weight loss, but these ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...
Eli Lilly and Company (NYSE:LLY) offers a quarterly dividend of $1.50 per share and has a dividend yield of 0.71%, as of March 20. It is one of the best dividend stocks on our list as the company has ...
The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a ...
Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese pharmaceutical company the United Bio-Technology (Hengqin) Co., as it looks to ...
The U.S. equity market has had a solid run in the past two years, buoyed by a steadily improving macroeconomic environment ...
JNJ announces plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the ...
Eli Lilly and Novo Nordisk have scored big wins from the FDA in recent months, as the agency cracks down on copycat versions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results